Back to Top Skip to main content Skip to sub-navigation

Surveillance for Vector-borne Diseases Among Active and Reserve Component Service Members, U.S. Armed Forces, 2016–2020

This image depicts a dorsal view of a female lone star tick, Amblyomma americanum, and is found in the Southeastern, and Mid-Atlantic United States. Females exhibit the star-like spot on their distal scutum. This tick is a vector of several zoonotic diseases, including human monocytic ehrlichiosis, and Rocky Mountain spotted fever (RMSF).  CDC/Michael L. Levin, PhD This image depicts a dorsal view of a female lone star tick, Amblyomma americanum, and is found in the Southeastern, and Mid-Atlantic United States. Females exhibit the star-like spot on their distal scutum. This tick is a vector of several zoonotic diseases, including human monocytic ehrlichiosis, and Rocky Mountain spotted fever (RMSF).

CDC/Michael L. Levin, PhD

Recommended Content:

Medical Surveillance Monthly Report

WHAT ARE THE NEW FINDINGS?

In the last decade, the most common vector-borne diseases among U.S. Armed Forces tended to be Lyme disease, malaria, Rocky Mountain spotted fever, dengue, and leishmaniasis. During 2014–2016, the pandemics of chikungunya and Zika virus transiently inserted those diseases into the top 5. The declining incidences of malaria and leishmaniasis during 2016–2020 are likely due to reduced numbers of service members assigned to endemic regions of the world.

WHAT IS THE IMPACT ON READINESS AND FORCE HEALTH PROTECTION?

The current findings reemphasize that the threat to service members from vector-borne diseases will vary according to the prevalent endemic diseases of specific geographic locations, the availability of protective vaccines, and the implementation of individual and group preventive measures.

ABSTRACT

This report summarizes data from electronic reports of reportable medical events (RMEs) to examine the incidence of vector-borne infectious diseases among members of the U.S. Armed Forces during a recent 5-year period. Case reports of such diseases were characterized as confirmed, probable, or suspected by the senders of the RME reports. Records of inpatient and outpatient care were not searched to find additional cases. Lyme disease and malaria were the most common diagnoses among confirmed cases. The next most common diagnoses were Zika virus infection, Rocky Mountain spotted fever, and dengue. Those 5 diseases were responsible for 94% of all confirmed vector-borne diseases reported as RMEs. Among the 1,068 RMEs for vector-borne diseases (confirmed, probable, and suspected), there were only 105 such cases that could be linked to a record of hospitalization for the same diagnosis.

BACKGROUND

The U.S. Armed Forces and the Department of Defense (DoD) have traditionally dedicated considerable effort to the prevention and treatment of vector-borne diseases that may adversely affect the ability of military service members to train for and execute their operational mission. A continuing element of that effort has been the performance of surveillance of vector-borne illnesses to guide preventive actions. The pages of the MSMR reflect over 25 years of surveillance studies to inform military leaders and preventive medicine/public health assets about the incidence of vector-borne diseases and appropriate steps to counter the associated threat. The February 2018 issue of the MSMR contained the results of the most recent, broad surveillance study of the most concerning vector-borne diseases.1 This article presents an updated review of this subject, utilizing a modified methodology for capturing the occurrence of cases.

METHODS

The surveillance period was 1 January 2016 through 31 December 2020. The surveillance population included all active and reserve component service members in the Army, Navy, Air Force, or Marine Corps who served at any time during the surveillance period. It is DoD policy that cases of certain specified medical conditions and events of public health importance shall be reported electronically through military health channels for surveillance purposes.2 Conditions covered by this policy are referred to as reportable medical events (RMEs). The content of such electronic reports is stored in the databases of the Defense Medical Surveillance System (DMSS), which was used to ascertain cases for this analysis. The vector-borne diseases that are the focus of this report are listed in Table 1. Almost all vector-borne diseases of concern for military service members are designated as RMEs.

For this analysis, a “confirmed”, “probable”, or “suspected” case was defined as an individual identified through an RME report of a vector-borne disease that was described as “confirmed”, “probable”, or “suspect” by having met specified laboratory or epidemiologic criteria.2 An individual could be counted once per lifetime for each type of vector-borne disease. For example, an individual could be counted once for malaria and once for leishmaniasis during the surveillance period. Individuals diagnosed as a case prior to the start of the surveillance period were excluded. Confirmed cases were prioritized over probable and suspected cases, respectively. 

A case was considered to be hospitalized if they had an inpatient admission within 30 days before or after the date of onset reported in the RME. In addition, the inpatient record had to include a diagnosis for the vector-borne disease as listed in Table 1 in any of the diagnostic positions. The total number of cases hospitalized, as well as the percentage hospitalized and number of bed days were summarized for each vector-borne disease.

RESULTS

During the 5-year surveillance period, the electronic records of RMEs identified 709 confirmed cases of vector-borne diseases, 196 probable cases, and 163 suspected cases among service members of the active and reserve components (Table 2). Active component service members comprised 86% of confirmed cases, 84% of probable cases, and 83% of suspected cases. There were no RMEs for any of the diagnoses of hemorrhagic fevers, filariasis, plague, relapsing fever, or yellow fever. The category “Arboviral diseases, neuro-invasive and non-neuroinvasive” included 3 cases of confirmed West Nile virus infection, 1 case of confirmed tick born encephalitis (TBE), and 4 unspecified types, for a total of 8 confirmed cases in that category. Only the 14 diagnostic categories displayed in Table 2 had any RMEs during the 5-year period.

Of the total of 709 confirmed cases, 668 (94%) were associated with RME diagnoses of Lyme disease (n=311), malaria (n=172), Zika virus infection (n=80), Rocky Mountain spotted fever (RMSF) (n=54), and dengue fever (n=51). The other diagnoses that were reported as confirmed cases were much less commonly documented (Table 2).

The distribution of diagnoses among probable RME cases was different from that of confirmed cases. It was noteworthy that Lyme disease was the diagnosis for 53 (27%) of the 196 probable cases, but RMSF accounted for 116 (59%) of the total probable cases. None of the other diagnoses was reported more than 5 times as probable cases during the 5 year surveillance period (Table 2).

Among the suspected cases, the most common RMEs were for Lyme disease (n=74), RMSF (n=54), and Zika virus infection (n=14). Together those three diagnoses were the subject of 87% of suspected cases of RMEs (Table 2). For the results described below, the emphasis will be on confirmed cases.

Lyme disease

Lyme disease accounted for 43.8% of all confirmed RME cases and was the most common of the vector-borne diseases reported during 2016–2020. The annual numbers of confirmed cases were greatest in 2016 and lowest in 2018, when the number of Lyme disease cases was actually lower than the count of malaria cases (Figure 1). The numbers of probable and suspected cases of Lyme disease (n=127) were actually lower than the counts for RMSF (n=170) during the surveillance period (Table 2).

Malaria

Diagnoses of malaria (n=172) contributed 24.2% of all confirmed RME cases of vector-borne diseases during the 5 year surveillance period. The highest count was in 2018 (n=51) but the most recent two years had the lowest counts of the period (n=26 and 20, respectively) (Figure 1). There were only 12 cases of malaria in RME reports of probable and suspected cases (Table 2).

Zika virus infection

Confirmed cases of Zika virus infection numbered 80 during the period (Table 2). However, 73 of those cases were reported in 2016, with the remainder reported in 2017 (n=4), 2019 (n=2), and 2020 (n=1) (data not shown). Zika virus was introduced into the Americas in 2015 and the case counts in the U.S. as well as in the U.S. Armed Forces peaked in 2016.3 Of the 16 service member cases reported as probable or suspected, 12 were reported in 2016 (data not shown).

Rocky Mountain spotted fever

Confirmed cases of RMSF (n=54), unlike all other diagnoses that are reportable, were outnumbered by reports of probable (n=116) and suspected (n=54) cases of RMSF (Table 2). This phenomenon is likely the result of the necessity to confirm the diagnosis of RMSF (and related rickettsial diseases) via the performance of acute and convalescent serological studies or other more sophisticated tests such as a PCR test for DNA, immunohistochemistry of a biopsy specimen, or a positive culture. The current RME guidelines include RMSF in the broader category of Spotted Fever Rickettsiosis, which includes conditions with similar clinical presentations that may be distinguished only with the testing procedures mentioned above.

Dengue

Of the total of 60 cases of dengue reported via RME, 51 were described as confirmed (Table 2). At least 18 of those confirmed cases were reported by an overseas treatment facility and an additional 14 cases were linked to an overseas travel location. The most commonly cited of those locations were Djibouti (n=7) and the Philippines (n=5). There were relatively few RME cases of dengue that were classified as probable (n=5) or suspected (n=4) (data not shown).

Leishmaniasis

There were 16 confirmed cases of leishmaniasis reported during the period but only 2 of them were reported in 2019 and none in 2020 (Table 2, data not shown). Of the 6 cases for which the reports mention a location where the service member may have acquired the infection, 5 specify either Iraq, Afghanistan, or Syria and 1 mentions Palau (data not shown). Probable cases numbered 2 and there were no suspected cases.

Arboviral diseases, neuroinvasive and nonneuroinvasive

The 3 confirmed cases and 1 suspected case of West Nile virus infection were diagnosed in the continental U.S. and the single confirmed and probable cases of tick-borne encephalitis were diagnosed in Germany (data not shown). Among the total of 12 cases that were reported in this broad category, 7 were associated with Germany and 5 with the U.S. (data not shown).

Other

The remaining 5 diagnostic categories of RMEs were associated with a total of 17 confirmed cases, 12 probable cases, and 7 suspected cases over the 5-year surveillance period (Table 2). The most recent confirmed cases of chikungunya were 2 that were diagnosed in 2019 and they were associated with recent travel to the Philippines and Djibouti, respectively (data not shown).

Hospitalizations

During the 5-year surveillance period, there were 1,068 RME reports submitted for confirmed, probable, and suspected cases. Associated with the service members who were the subjects of those reports, there were 105 instances of hospitalization for which the records of inpatient care specified the diagnosis of the reportable condition. Such hospitalizations reflected only 6 different reportable diagnoses (Table 3). Of the 184 reported cases of malaria, 43.5% were associated with hospitalizations (n=80) for which a malaria diagnosis was recorded. For Lyme disease, the 11 hospitalizations represented 2.5% of all RME diagnoses of that condition; for dengue, the 7 hospitalizations were associated with 11.7% of all RME diagnoses; for arboviral diseases, there were 4 hospitalizations representing 33.3% of all cases that were reported. Finally, there were single hospitalizations for RMSF and typhus that represented .4% and 20% of RMEs for those respective diagnoses (Table 3).

EDITORIAL COMMENT

The identities of the most common vector-borne diseases in this analysis were similar to those documented in previous studies. For example, MSMR reports covering the years 1995–1999 and 2010–2016 noted that the most common diseases included Lyme disease, malaria, RMSF, dengue fever, and leishmaniasis, just as was the case for 2016–2020.1,4 The only exceptions to the lists of most common diseases were due to the pandemic occurrences of chikungunya and Zika virus infections starting in 2013.3,5

The methods employed in this surveillance study differed significantly from the two studies previously mentioned. The counts for 2016–2020 were based solely on RMEs electronically submitted by public health/preventive medicine specialists who evaluated the available information for each case in order to render an evaluation as to whether or not the diagnosis was confirmed, probable, or suspected. The previous studies utilized DMSS records of hospitalizations and/or outpatient encounters to identify cases. It is most noteworthy that using only the documentation of outpatient diagnoses to qualify as a “suspected” case, as was one of the criteria in 2010–2016, is a highly sensitive, but very non-specific means of identifying cases. The employment of just RMEs to identify and count cases of vector-borne diseases increases the probability they are true cases of the diseases of interest. However, the omission of inpatient and outpatient diagnoses of these diseases likely yields an underestimate of the true incidence of some of the conditions.

The analysis of hospitalizations among RME cases revealed that most reportable vector-borne diseases were not associated with a hospitalization within 30 days before or after the reported date of illness onset. The correlation between hospitalization and diagnosis of a reportable disease is mainly a reflection of the severity of illness. The diseases of interest in this study have a broad spectrum of clinical severity and, in particular, if a given disease can be readily treated with a highly effective antimicrobial agent, then rates of hospitalization may be quite low.

The reader is referred to the February 2018 MSMR article on this subject for further discussion of the topics of Lyme disease incidence in the U.S., the years of peak incidence of chikungunya and Zika virus infections, the declining incidence of leishmaniasis associated with reduced presence of service members in the Middle East, and the pitfalls of using outpatient diagnoses for surveillance.1

REFERENCES

1. O’Donnell FL, Stahlman S, Fan M. Surveillance for vector-borne diseases among active and reserve component service members, U.S. Armed Forces, 2010–2016. MSMR. 2018;25:8–15.

2.  Defense Health Agency. Armed Forces Reportable Medical Events. Guidelines and Case Definitions. January 2020.

3.  Ikejezie J, Shapiro CN, Kim J, et al. Zika virus transmission–Region of the Americas, May 15, 2015 – December 15, 2016. MMWR Morb Mortal Wkly Rep. 2017;66:329–334.

4.  Garvey AL. Five most common arthropodborne diseases among active duty service members in the U.S. Armed Forces, 1995-1999. MSMR. 2000;6:12–16.

5.   Fischer M, Staples JE. Notes from the field. Chikungunya virus spreads in the Americas – Caribbean and South America, 2013–2014. MMWR Morb Mortal Wkly Rep. 2014:63:500–501.

FIGURE. Annual counts of confirmed cases of most common RMEs, active and reserve components, U.S. Armed Forces, 2016–2020

TABLE 1. Reportable vector-borne diseases, with ICD-10 diagnostic codes, type of infectious agent, type of vectors, geographic distribution, and availability of FDA-approved vaccine

TABLE 2. Numbers of confirmed, probable, and suspected cases of vector-borne diseases, active and reserve components, U.S. Armed Forces, 2016–2020

TABLE 3. Frequency of hospitalizations of service members with RMEs for vector-borne diseases and associated number of hospital bed days, active and reserve components, U.S. Armed Forces, 2016–2020

You also may be interested in...

Sexually Transmitted Infections

Infographic
3/20/2019
Sexually Transmitted Infections

This report summarizes incidence rates of the 5 most common sexually transmitted infections (STIs) among active component service members of the U.S. Armed Forces during 2010–2018.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Vasectomy

Infographic
3/20/2019
Vasectomy

There are few published studies of vasectomy and vasectomy reversal among the U.S. military population. To address these gaps, the current analysis describes the overall and annual incidence rates of vasectomy among active component service men during 2000–2017 by demographic and military characteristics and by type of surgical vas isolation procedure used. In addition, the median age at incident vasectomy and the time between incident vasectomy and first vasectomy reversal are described.

Recommended Content:

Health Readiness | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Testosterone Replacement Therapy

Infographic
3/20/2019
Testosterone Replacement Therapy

With the increasing number of testosterone deficiency diagnoses and potential health risks associated with initiation of TRT, it is important to understand the epidemiology of which U.S. service men are receiving TRT and whether these individuals have an indication for receiving treatment.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Male Infertility

Infographic
3/20/2019
Male Infertility

The current report updates and expands on the findings of the previous MSMR analysis of infertility among active component service men. Specifically, the current report summarizes the frequencies, rates, temporal trends, types of infertility, and demographic and military characteristics of infertility among active component service men during 2013–2017.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Brief Report: Male Infertility, Active Component, U.S. Armed Forces, 2013–2017

Article
3/1/2019
Sperm is the male reproductive cell  Photo: iStock

Infertility, defined as the inability to achieve a successful pregnancy after 1 year or more of unprotected sexual intercourse or therapeutic donor insemination, affects approximately 15% of all couples. Male infertility is diagnosed when, after testing both partners, reproductive problems have been found in the male. A male factor contributes in part or whole to about 50% of cases of infertility. However, determining the true prevalence of male infertility remains elusive, as most estimates are derived from couples seeking assistive reproductive technology in tertiary care or referral centers, population-based surveys, or high-risk occupational cohorts, all of which are likely to underestimate the prevalence of the condition in the general U.S. population.

Recommended Content:

Medical Surveillance Monthly Report

Vasectomy and Vasectomy Reversals, Active Component, U.S. Armed Forces, 2000–2017

Article
3/1/2019
Sperm is the male reproductive cell  Photo: iStock

During 2000–2017, a total of 170,878 active component service members underwent a first-occurring vasectomy, for a crude overall incidence rate of 8.6 cases per 1,000 person-years (p-yrs). Among the men who underwent incident vasectomy, 2.2% had another vasectomy performed during the surveillance period. Compared to their respective counterparts, the overall rates of vasectomy were highest among service men aged 30–39 years, non-Hispanic whites, married men, and those in pilot/air crew occupations. Male Air Force members had the highest overall incidence of vasectomy and men in the Marine Corps, the lowest. Crude annual vasectomy rates among service men increased slightly between 2000 and 2017. The largest increases in rates over the 18-year period occurred among service men aged 35–49 years and among men working as pilots/air crew. Among those who underwent vasectomy, 1.8% also had at least 1 vasectomy reversal during the surveillance period. The likelihood of vasectomy reversal decreased with advancing age. Non-Hispanic black and Hispanic service men were more likely than those of other race/ethnicity groups to undergo vasectomy reversals.

Recommended Content:

Medical Surveillance Monthly Report

Testosterone Replacement Therapy Use Among Active Component Service Men, 2017

Article
3/1/2019
Marines carry a wooden log for physical fitness

This analysis summarizes the prevalence of testosterone replacement therapy (TRT) during 2017 among active component service men by demographic and military characteristics. This analysis also determines the percentage of those receiving TRT in 2017 who had an indication for receiving TRT using the 2018 American Urological Association (AUA) clinical practice guidelines. In 2017, 5,093 of 1,076,633 active component service men filled a prescription for TRT, for a period prevalence of 4.7 per 1,000 male service members. After adjustment for covariates, the prevalence of TRT use remained highest among Army members, senior enlisted members, warrant officers, non-Hispanic whites, American Indians/Alaska Natives, those in combat arms occupations, healthcare workers, those who were married, and those with other/unknown marital status. Among active component male service members who received TRT in 2017, only 44.5% met the 2018 AUA clinical practice guidelines for receiving TRT.

Recommended Content:

Medical Surveillance Monthly Report

Sexually Transmitted Infections, Active Component, U.S. Armed Forces, 2010–2018

Article
3/1/2019
Anopheles merus

This report summarizes incidence rates of the 5 most common sexually transmitted infections (STIs) among active component service members of the U.S. Armed Forces during 2010–2018. Infections with chlamydia were the most common, followed in decreasing order of frequency by infections with genital human papillomavirus (HPV), gonorrhea, genital herpes simplex virus (HSV), and syphilis. Compared to men, women had higher rates of all STIs except for syphilis. In general, compared to their respective counterparts, younger service members, non-Hispanic blacks, soldiers, and enlisted members had higher incidence rates of STIs. During the latter half of the surveillance period, the incidence of chlamydia and gonorrhea increased among both male and female service members. Rates of syphilis increased for male service members but remained relatively stable among female service members. In contrast, the incidence of genital HPV and HSV decreased among both male and female service members. Similarities to and differences from the findings of the last MSMR update on STIs are discussed.

Recommended Content:

Medical Surveillance Monthly Report

Adenovirus

Infographic
3/1/2019
Adenovirus

During August–September 2016, U.S. Naval Academy clinical staff noted an increase in students presenting with acute respiratory illness (ARI). An investigation was conducted to determine the extent and cause of the outbreak.

Recommended Content:

Health Readiness | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Malaria

Infographic
3/1/2019
Malaria

Since 1999, the Medical Surveillance Monthly Report has published regular updates on the incidence of malaria among U.S. service members. The MSMR’s focus on malaria reflects both historical lessons learned about this mosquito-borne disease and the continuing threat that it poses to military operations and service members’ health.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Division | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Glaucoma

Infographic
3/1/2019
Glaucoma

This report describes an analysis using the Defense Medical Surveillance System to identify all active component service members with an incident diagnosis of glaucoma during the period between 2013 and 2017.

Recommended Content:

Health Readiness | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Update: Malaria, U.S. Armed Forces, 2018

Article
2/1/2019
Anopheles merus

Malaria infection remains an important health threat to U.S. service mem­bers who are located in endemic areas because of long-term duty assign­ments, participation in shorter-term contingency operations, or personal travel. In 2018, a total of 58 service members were diagnosed with or reported to have malaria. This represents a 65.7% increase from the 35 cases identi­fied in 2017. The relatively low numbers of cases during 2012–2018 mainly reflect decreases in cases acquired in Afghanistan, a reduction due largely to the progressive withdrawal of U.S. forces from that country. The percentage of cases of malaria caused by unspecified agents (63.8%; n=37) in 2018 was the highest during any given year of the surveillance period. The percent­age of cases identified as having been caused by Plasmodium vivax (10.3%; n=6) in 2018 was the lowest observed during the 10-year surveillance period. The percentage of malaria cases attributed to P. falciparum (25.9 %) in 2018 was similar to that observed in 2017 (25.7%), although the number of cases increased. Malaria was diagnosed at or reported from 31 different medical facilities in the U.S., Afghanistan, Italy, Germany, Djibouti, and Korea. Pro­viders of medical care to military members should be knowledgeable of and vigilant for clinical manifestations of malaria outside of endemic areas.

Recommended Content:

Medical Surveillance Monthly Report

Update: Incidence of Glaucoma Diagnoses, Active Component, U.S. Armed Forces, 2013–2017

Article
2/1/2019
Glaucoma

Glaucoma is an eye disease that involves progressive optic nerve damage and vision loss, leading to blindness if undetected or untreated. This report describes an analysis using the Defense Medical Surveillance System to identify all active component service members with an incident diagnosis of glaucoma during the period between 2013 and 2017. The analysis identified 37,718 incident cases of glaucoma and an overall incidence rate of 5.9 cases per 1,000 person-years (p-yrs). The majority of cases (97.6%) were diagnosed at an early stage as borderline glaucoma; of these borderline cases, 2.2% progressed to open-angle glaucoma during the study period. No incident cases of absolute glaucoma, or total blindness, were identified. Rates of glaucoma were higher among non-Hispanic black (11.0 per 1,000 p-yrs), Asian/Pacific Islander (9.5), and Hispanic (6.9) service members, compared with non-Hispanic white (4.0) service members. Rates among female service members (6.6 per 1,000 p-yrs) were higher than those among male service members (5.8). Between 2013 and 2017, incidence rates of glaucoma diagnoses increased by 75.4% among all service members.

Recommended Content:

Medical Surveillance Monthly Report

Outbreak of Acute Respiratory Illness Associated with Adenovirus Type 4 at the U.S. Naval Academy, 2016

Article
2/1/2019
Malaria case definition

Human adenoviruses (HAdVs) are known to cause respiratory illness outbreaks at basic military training (BMT) sites. HAdV type-4 and -7 vaccines are routinely administered at enlisted BMT sites, but not at military academies. During August–September 2016, U.S. Naval Academy clinical staff noted an increase in students presenting with acute respiratory illness (ARI). An investigation was conducted to determine the extent and cause of the outbreak. During 22 August–11 September 2016, 652 clinic visits for ARI were identified using electronic health records. HAdV-4 was confirmed by real-time polymerase chain reaction assay in 18 out of 33 patient specimens collected and 1 additional HAdV case was detected from hospital records. Two HAdV-4 positive patients were treated for pneumonia including 1 hospitalized patient. Molecular analysis of 4 HAdV-4 isolates identified genome type 4a1, which is considered vaccine-preventable. Understanding the impact of HAdV in congregate settings other than enlisted BMT sites is necessary to inform discussions regarding future HAdV vaccine strategy.

Recommended Content:

Medical Surveillance Monthly Report

Re-evaluation of the MSMR Case Definition for Incident Cases of Malaria

Article
2/1/2019
Anopheles merus

The MSMR has been publishing the results of surveillance studies of malaria since 1995. The standard MSMR case definition uses Medical Event Reports and records of hospitalizations in counting cases of malaria. This report summarizes the performance of the standard MSMR case definition in estimating incident cases of malaria from 2015 through 2017. Also explored was the potential surveillance value of including outpatient encounters with diagnoses of malaria or positive laboratory tests for malaria in the case definition. The study corroborated the relative accuracy of the MSMR case definition in estimating malaria incidence and provided the basis for updating the case definition in 2019 to include positive laboratory tests for malaria antigen within 30 days of an outpatient diagnosis.

Recommended Content:

Medical Surveillance Monthly Report
<< < ... 6 7 8 9 10  ... > >> 
Showing results 136 - 150 Page 10 of 14

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.